Cargando…
Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer
FBXW7 is a component of SCF (complex of SKP1, CUL1 and F-box-protein)-type ubiquitin ligases that targets several oncoproteins for ubiquitination and degradation by the proteasome. FBXW7 regulates cellular apoptosis by targeting MCL1 for ubiquitination. Recently, we identified PLK1 as a new substrat...
Autores principales: | Gasca, Jessica, Flores, Maria Luz, Giráldez, Servando, Ruiz-Borrego, Manuel, Tortolero, María, Romero, Francisco, Japón, Miguel A., Sáez, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288146/ https://www.ncbi.nlm.nih.gov/pubmed/27409838 http://dx.doi.org/10.18632/oncotarget.10481 |
Ejemplares similares
-
SCF(FBXW7α) modulates the intra-S-phase DNA-damage checkpoint by regulating Polo like kinase-1 stability
por: Giráldez, Servando, et al.
Publicado: (2014) -
p53 and FBXW7: Sometimes Two Guardians Are Worse than One
por: Galindo-Moreno, María, et al.
Publicado: (2020) -
βTrCP controls the lysosome-mediated degradation of CDK1, whose accumulation correlates with tumor malignancy
por: Herrero-Ruiz, Joaquín, et al.
Publicado: (2014) -
Both p62/SQSTM1-HDAC6-dependent autophagy and the aggresome pathway mediate CDK1 degradation in human breast cancer
por: Galindo-Moreno, María, et al.
Publicado: (2017) -
Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells
por: Jiménez-Guerrero, Rocío, et al.
Publicado: (2018)